BioAscent's compound management facility in Scotland is in the perfect location to support US biotechs with cost-effective and secure compound management, whilst helping them to connect their CRO network, and accelerate their design-make-test cycles. Operating since 2005, our €20 million facility stores and manages customer libraries ranging in size from tens to hundreds-of-thousands of compounds in both liquid and solid formats.
